Lori J. Wirth, MD, on Optimizing Therapy for Thyroid Cancer: Clinical Pearls

Posted: Tuesday, March 30, 2021

Lori J. Wirth, MD, of Massachusetts General Hospital Cancer Center, discusses how new regimens may be changing the prognoses for patients with thyroid cancer subtypes that are not amenable to standard treatment and whether community practitioners should refer patients with more rare tumor types to an academic medical center.